Friday, September 22, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
AbbVie Inc.
Supported by an independent educational grant from
Bristol Myers Squibb
Supported by an independent educational grant from
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Supported by an independent educational grant from
Karyopharm Therapeutics
Supported by an independent educational grant from
Legend Biotech
Supported by an independent educational grant from
Sanofi
Supported by an independent educational grant from
Takeda Pharmaceuticals U.S.A., Inc.
Steering Committee Chair
Professor of Medicine
Chief of Myeloma Program & Experimental Therapeutics Programs
Sylvester Comprehensive Cancer Center
University of Miami
Miller School of Medicine
Miami, Florida
Steering Committee Member
Associate Clinical Professor of Medicine
UC San Diego Health
Division of Blood and Marrow Transplant
Moores Cancer Center
La Jolla, California
Steering Committee Member
Director of Judy and Bernard Briskin Multiple Myeloma Center
Professor of Hematology/Hematopoietic Cell Transplantation
City of Hope Cancer Center
Duarte, California
Steering Committee Member
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, Georgia
Steering Committee Member
Assistant Professor of Medicine
Hematology/Oncology Nurse Practitioner
University of Arizona Cancer Center
Tucson, Arizona
Steering Committee Member
Professor, Applied Cancer Research and Drug Discovery
Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Phoenix, Arizona
Steering Committee Chair
Has the following relevant financial relationships:
Speaker or member of speakers bureau for: Adaptive Biotechnologies; Amgen, Inc.; Bristol Myers Squibb Company; Celgene Corporation; GlaxoSmithKline; Janssen; Pfizer, Inc.
Research funding from: Amgen, Inc.; Janssen; Pfizer, Inc.
Other: Independent Data Monitoring Committee (IDMC) for safety monitoring for clinical trials: Janssen; Takeda; Theradex
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb Company; Janssen; Pfizer, Inc.; Takeda
Research funding from: Bristol Myers Squibb Company; Pfizer, Inc.; Takeda
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Adaptive Biotechnologies; Bristol Myers Squibb Company; GlaxoSmithKline; Janssen; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; Sutro Biopharma, Inc.
Speaker or member of speakers bureau for: Bristol Myers Squibb Company; GlaxoSmithKline; Takeda
Research funding from: Janssen
Contracted researcher for: Janssen; Sutro Biopharma, Inc.; Takeda
Owns stock (publicly traded) in: Bristol Myers Squibb Company
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Amgen, Inc.; Bristol Myers Squibb Company; Celgene Corporation; Genentech; GlaxoSmithKline; Janssen; Novartis; Takeda
Research funding from: Bristol Myers Squibb Company; Janssen; Novartis; Takeda
Owns stock (publicly traded) in: TG Therapeutics
Other: Board of Directors for TG Therapeutics
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Aggios; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Bristol Myers Squibb Company; Takeda
Speaker or member of speakers bureau for: AbbVie Inc.; Bristol Myers Squibb Company; Takeda
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Amgen, Inc.; Bristol Myers Squibb Company; Janssen; Karyopharm; Pfizer, Inc.; Sanofi; Takeda
Research funding from: Bristol Myers Squibb Company
